#2521 ·
Kate Wells44 said:I’ve explained this before—re-irradiation is absolutely on the table and makes perfect sense if the initial radiation treatment was successful. It isn't a one-size-fits-all decision; an oncology tumor board reviews each patient individually to decide the best path forward.
In the US, we don't usually see this specific issue, but in many healthcare systems, lung cancer patients are often managed by pulmonologists rather than oncologists. This leads to a breakdown in coordination, leaving patients to wander through the system trying to find the right specialists. That is exactly what you are experiencing firsthand.
As an oncologist, I see this systemic friction all the time.
Well, you’ve certainly given me a lot to chew on now—I’ll probably end up having a million follow-up questions... Is it possible to seek a second opinion from an oncologist specifically? Or does it have to be a pulmonologist? And what are the standard protocols for small cell carcinoma here in the States? In her case, the pulmonologist suggested PE as the first line, then Hycamtin, followed by CAV. If the disease progresses more than six months after receiving PE, they go back to it.
Now, I’m hearing that Taxol is typically administered between the Hycamtin and CAV protocols—and apparently, if all those protocols are exhausted and six months have passed since the last platinum-based treatment, they might switch to a different type of platinum. Radiation for the primary tumor wasn't even an option for her from the start. Why would that be? Also—and please excuse my directness—would it be alright if I sent over his lab results and CT scans? :-)